Osaic Holdings’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,406
| Closed | -$551K | – | 7390 |
|
|
2023
Q2 | $551K | Sell |
5,406
-2,863
| -35% | -$292K | ﹤0.01% | 3063 |
|
|
2023
Q1 | $752K | Buy |
8,269
+6,717
| +433% | +$611K | ﹤0.01% | 2751 |
|
|
2022
Q4 | $58K | Buy |
1,552
+1,524
| +5,443% | +$56.9K | ﹤0.01% | 4822 |
|
|
2022
Q3 | $0 | Sell |
28
-11
| -28% | – | ﹤0.01% | 7477 |
|
|
2022
Q2 | $0 | Sell |
39
-204
| -84% | – | ﹤0.01% | 7506 |
|
|
2022
Q1 | $7K | Buy |
243
+18
| +8% | +$519 | ﹤0.01% | 6310 |
|
|
2021
Q4 | $6K | Sell |
225
-1,115
| -83% | -$29.7K | ﹤0.01% | 6488 |
|
|
2021
Q3 | $138K | Sell |
1,340
-346
| -21% | -$35.6K | ﹤0.01% | 4249 |
|
|
2021
Q2 | $240K | Sell |
1,686
-553
| -25% | -$78.7K | ﹤0.01% | 3710 |
|
|
2021
Q1 | $223K | Sell |
2,239
-237
| -10% | -$23.6K | ﹤0.01% | 3636 |
|
|
2020
Q4 | $306K | Buy |
2,476
+588
| +31% | +$72.7K | ﹤0.01% | 3105 |
|
|
2020
Q3 | $184K | Buy |
1,888
+1,725
| +1,058% | +$168K | ﹤0.01% | 3330 |
|
|
2020
Q2 | $26K | Buy |
163
+158
| +3,160% | +$25.2K | ﹤0.01% | 4622 |
|
|
2020
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 6131 |
|